Ask Anything
LIVEESC Congress 2026Munich · Aug 28-31 · Hot Line trials and the live discussion from MunichOpen the hub→Hot Research Today
Papers from every journal, all in one place. Create custom feeds.
ESC 2026 Hot LineRCT · n=5589 mentionsACC Journal Scan (X) Highlight
AUG 31KroupaNew England Journal of Medicine
Catheter-directed thrombolysis reduces mortality, PE recurrence, or decompensation ~90% vs standard anticoagulation.
Supports catheter-directed thrombolysis in intermediate-high-risk PE; confirms early-event reduction versus anticoagulation alone in this RCT.
VKViktor Kočka
In contrast to interventions for myocardial infarction or stroke, there have been very few advances in the treatment of [PE] over the last 20 years. This has led to a considerable unmet clinical need that we can't ignore.
RCT · n=12,2578 mentionsTrending on XCirculation Highlight
AUG 31GiuglianoCirculation
Evolocumab reduces all-cause mortality ~20% vs placebo in high-risk patients without prior MI or stroke.
Reduces all-cause mortality in high-risk patients without prior MI or stroke; extends VESALIUS-CV event reduction to survival benefit.
JBDr. Jay Bradner
Executive Vice President, Research and Development, Artificial Intelligence and Data, Amgen
For people at high risk of a heart attack or stroke, lowering LDL-C or 'bad' cholesterol with Repatha may do more than help prevent these events; it may also reduce the risk of dying from heart disease and its serious consequences. This is especially significant given cardiovascular disease remains the leading cause of death worldwide. The totality of these data is practice-changing and reinforces the importance of identifying high-risk patients early and lowering LDL-C aggressively and consistently with Repatha.
RCT1 mentions
AUG 31PetersenCirculation
Letter by Petersen et al Regarding Article, “Randomized Controlled Trial of Mechanical Thrombectomy With Anticoagulation Versus Anticoagulation Alone for Acute Intermediate-High Risk Pulmonary Embolism: Primary Outcomes From the STORM-PE Trial”
Correspondence examines mechanical thrombectomy with anticoagulation for intermediate-high risk pulmonary embolism, highlighting clinical considerations from the STORM-PE trial.
cohort · n=1,1246 mentions
AUG 31HauptmannJAMA Cardiology
Disease-specific TR grading in ATTR-CM improves mortality prediction over standard schemes, linking to ~41% greater risk.
May refine TR risk stratification in ATTR-CM; challenges standard grading from nonamyloid populations and remains hypothesis-generating.
SCDr. Spencer J Carter
Cardiologist, National Institutes of Health
In #TransthyretinCardiacAmyloidosis, conventional thresholds for #TricuspidRegurgitation may underestimate risk because even modest regurgitant volumes can represent a meaningful loss of effective forward flow in a restrictive, low-stroke-volume physiology. This editorial indicates that disease-specific thresholds may improve prognostic assessment once transthyretin amyloid cardiomyopathy has been established.
cohort · n=1,1256 mentions
SEP 2ManzanaresJACC Advances
Elevated HFpEF-ABA scores linked to ~141% higher risk of death or HF hospitalization.
The HFpEF-ABA score provides moderate diagnostic discrimination for HFpEF and identifies outpatients with type 2 diabetes at high risk for adverse clinical outcomes.
VSDr. Varun Sundaram
Heart Failure Cardiologist, University Hospitals Harrington Heart & Vascular Institute
With the new, simple scoring system, 'We are able to screen and effectively identify patients with a high probability of HFpEF at the population level.' We're tapping into an opportunity to elevate the standard of care, and it will change the paradigm for diagnosis for better identification of HFpEF at the community level.
cohort · n=732 mentionsTrending on X
AUG 31AmirEuropean Journal of Heart Failure
Higher left atrial pressure is linked to ~40% greater risk of ADHF events.
Evening LAP elevation may aid ADHF risk stratification in chronic HF; hypothesis-generating for diurnal monitoring, pending prospective trials.
cohort2 mentionsTrending on X
SEP 1BalNature Cardiovascular Research
Highest multiancestry PRS quintile linked to ~111% greater HCM risk.
Highest PRS quintile associated with elevated HCM risk in variant carriers; leaves open whether multiancestry PRS improves clinical stratification.
RCT · n=3202 mentionsTrending on X
SEP 1凌天佑EP Europace
First-line cryoballoon ablation cuts atrial tachyarrhythmia recurrence ~58% versus antiarrhythmic drugs.
Supports first-line cryoballoon ablation in treatment-naive persistent AF; extends randomized evidence from paroxysmal populations.
PHDr. Peter Steen Hansen
Cardiologist and Electrophysiologist, Rytmedoktor
For years, we have known that ablation is a safe and effective treatment for paroxysmal atrial fibrillation – episodes that come and go. However, there has been more skepticism regarding persistent atrial fibrillation, which does not resolve spontaneously. Several studies have shown that outcomes are generally less favorable in this group.
cohort · n=8081 mentions
AUG 31Płońska‐GościniakEuropean Heart Journal - Cardiovascular Imaging
Female sex in adults with BAV linked to ~49% greater prevalence of extended aortopathy.
Sex-specific BAV aortopathy patterns may inform surveillance; leaves open optimal normalization for risk stratification.
cohort · n=210,535Trending on X
AUG 31BrownellCirculation Heart Failure
COVID-19 pandemic linked to ~13% higher mortality in HF patients despite fewer hospitalizations.
Increased mortality despite fewer hospitalizations warrants vigilance in disrupted HF care; leaves open drivers of outcomes in veteran HFrEF cohorts.
